Thus, NfL levels are increased proportionally to the degree of damage,2 making serum NfL levels a useful biomarker for diagnosing and predicting disease progression of a variety of CNS disorders, including multiple sclerosis (MS).3 The gene discussed is NEFL; the disease is myeloid sarcoma.